42 related articles for article (PubMed ID: 26189437)
1. A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS.
Rosmarin D; Palles C; Pagnamenta A; Kaur K; Pita G; Martin M; Domingo E; Jones A; Howarth K; Freeman-Mills L; Johnstone E; Wang H; Love S; Scudder C; Julier P; Fernández-Rozadilla C; Ruiz-Ponte C; Carracedo A; Castellvi-Bel S; Castells A; Gonzalez-Neira A; Taylor J; Kerr R; Kerr D; Tomlinson I
Gut; 2015 Jan; 64(1):111-20. PubMed ID: 24647007
[TBL] [Abstract][Full Text] [Related]
2. Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.
Wilson PM; Danenberg PV; Johnston PG; Lenz HJ; Ladner RD
Nat Rev Clin Oncol; 2014 May; 11(5):282-98. PubMed ID: 24732946
[TBL] [Abstract][Full Text] [Related]
3. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.
Kelemen LE; Earp M; Fridley BL; Chenevix-Trench G; ; Fasching PA; Beckmann MW; Ekici AB; Hein A; Lambrechts D; Lambrechts S; Van Nieuwenhuysen E; Vergote I; Rossing MA; Doherty JA; Chang-Claude J; Behrens S; Moysich KB; Cannioto R; Lele S; Odunsi K; Goodman MT; Shvetsov YB; Thompson PJ; Wilkens LR; Dörk T; Antonenkova N; Bogdanova N; Hillemanns P; Runnebaum IB; du Bois A; Harter P; Heitz F; Schwaab I; Butzow R; Pelttari LM; Nevanlinna H; Modugno F; Edwards RP; Kelley JL; Ness RB; Karlan BY; Lester J; Orsulic S; Walsh C; Kjaer SK; Jensen A; Cunningham JM; Vierkant RA; Giles GG; Bruinsma F; Southey MC; Hildebrandt MAT; Liang D; Lu K; Wu X; Sellers TA; Levine DA; Schildkraut JM; Iversen ES; Terry KL; Cramer DW; Tworoger SS; Poole EM; Bandera EV; Olson SH; Orlow I; Vestrheim Thomsen LC; Bjorge L; Krakstad C; Tangen IL; Kiemeney LA; Aben KKH; Massuger LFAG; van Altena AM; Pejovic T; Bean Y; Kellar M; Cook LS; Le ND; Brooks-Wilson A; Gronwald J; Cybulski C; Jakubowska A; Lubiński J; Wentzensen N; Brinton LA; Lissowska J; Hogdall E; Engelholm SA; Hogdall C; Lundvall L; Nedergaard L; Pharoah PDP; Dicks E; Song H; Tyrer JP; McNeish I; Siddiqui N; Carty K; Glasspool R; Paul J; Campbell IG; Eccles D; Whittemore AS; McGuire V; Rothstein JH; Sieh W; Narod SA; Phelan CM; McLaughlin JR; Risch HA; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Gentry-Maharaj A; Ramus SJ; Wu AH; Pearce CL; Lee AW; Pike MC; Kupryjanczyk J; Podgorska A; Plisiecka-Halasa J; Sawicki W; Goode EL; Berchuck A;
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134598
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide screening of loci associated with drug resistance to 5-fluorouracil-based drugs.
Ooyama A; Okayama Y; Takechi T; Sugimoto Y; Oka T; Fukushima M
Cancer Sci; 2007 Apr; 98(4):577-83. PubMed ID: 17425594
[TBL] [Abstract][Full Text] [Related]
5. DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical Trial.
Boige V; Vincent M; Alexandre P; Tejpar S; Landolfi S; Le Malicot K; Greil R; Cuyle PJ; Yilmaz M; Faroux R; Matzdorff A; Salazar R; Lepage C; Taieb J; Laurent-Puig P
JAMA Oncol; 2016 May; 2(5):655-662. PubMed ID: 26794347
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic-guided dosing of fluoropyrimidines beyond
Maslarinou A; Manolopoulos VG; Ragia G
Front Pharmacol; 2023; 14():1184523. PubMed ID: 37256234
[TBL] [Abstract][Full Text] [Related]
7. Investigation of UTR Variants by Computational Approaches Reveal Their Functional Significance in
Shah H; Khan K; Badshah Y; Mahmood Ashraf N; Shabbir M; Trembley JH; Afsar T; Abusharha A; Razak S
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833174
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of TS and ENOSF1 Variants as a Biomarker in Response to Neoadjuvant Chemotherapy based on 5FU in Gastric Cancer Patients.
Arjmandi K; Ameli F; Salahshourifar I; Esfandbod M; Irani S
Asian Pac J Cancer Prev; 2022 Sep; 23(9):2983-2989. PubMed ID: 36172660
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer.
Dong SQ; Wang TM; Zhang JB; He YQ; Xue WQ; Wu ZY; Yang DW; Cao LJ; Huang JW; Li XZ; Zhang PF; Zheng XH; Jia WH
Cancer Res Treat; 2021 Jul; 53(3):724-732. PubMed ID: 33285053
[TBL] [Abstract][Full Text] [Related]
10. The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?
Simões AR; Fernández-Rozadilla C; Maroñas O; Carracedo Á
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33228198
[TBL] [Abstract][Full Text] [Related]
11. A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies.
Schaerer D; Froehlich TK; Hamzic S; Offer SM; Diasio RB; Joerger M; Amstutz U; Largiadèr CR
J Pers Med; 2020 Oct; 10(4):. PubMed ID: 33086767
[TBL] [Abstract][Full Text] [Related]
12. Severe Capecitabine Toxicity Associated With a Rare
Ly RC; Schmidt RE; Kiel PJ; Pratt VM; Schneider BP; Radovich M; Offer SM; Diasio RB; Skaar TC
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923881
[No Abstract] [Full Text] [Related]
13. A Genotyping/Phenotyping Approach with Careful Clinical Monitoring to Manage the Fluoropyrimidines-Based Therapy: Clinical Cases and Systematic Review of the Literature.
Conti V; De Bellis E; Manzo V; Sabbatino F; Iannello F; Dal Piaz F; Izzo V; Charlier B; Stefanelli B; Torsiello M; Iannaccone T; Coglianese A; Colucci F; Pepe S; Filippelli A
J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32899374
[TBL] [Abstract][Full Text] [Related]
14. The Role of
Abbasian MH; Ansarinejad N; Abbasi B; Iravani M; Ramim T; Hamedi F; Ardekani AM
Avicenna J Med Biotechnol; 2020; 12(3):157-164. PubMed ID: 32695278
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis.
Kim SY; Baek JY; Oh JH; Park SC; Sohn DK; Kim MJ; Chang HJ; Kong SY; Kim DY
Radiat Oncol; 2017 Mar; 12(1):62. PubMed ID: 28347333
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in 5-Fluorouracil-related enzymes predict pathologic response after neoadjuvant chemoradiation for rectal cancer.
Nelson B; Carter JV; Eichenberger MR; Netz U; Galandiuk S
Surgery; 2016 Nov; 160(5):1326-1332. PubMed ID: 27423551
[TBL] [Abstract][Full Text] [Related]
17. Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers.
Jacobs BA; Deenen MJ; Pluim D; van Hasselt JG; Krähenbühl MD; van Geel RM; de Vries N; Rosing H; Meulendijks D; Burylo AM; Cats A; Beijnen JH; Huitema AD; Schellens JH
Br J Clin Pharmacol; 2016 Sep; 82(3):706-16. PubMed ID: 27161955
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G to C substitution in the first 28-bp tandem repeat of the thymidylate synthase 2R allele.
Meulendijks D; Jacobs BA; Aliev A; Pluim D; van Werkhoven E; Deenen MJ; Beijnen JH; Cats A; Schellens JH
Int J Cancer; 2016 Jan; 138(1):245-53. PubMed ID: 26189437
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
